FDMT vs QCOM · rev $37.0K vs P/E 16, rev $44.28B
4D Molecular Therapeutics Inc (FDMT) versus Qualcomm Incorporated (QCOM) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
FDMT currently screens at market cap $518.1M. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Not investment advice. Open the FDMT and QCOM stock pages for the full models.
Not investment advice.